Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Sarah Schoch"'
Autor:
Roger deAlwis, Sarah Schoch, Mazharul Islam, Christina Möller, Börje Ljungberg, Håkan Axelson
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 9, Iss 4, Pp 261-272 (2023)
Abstract Prognostic tools are an essential component of the clinical management of patients with renal cell carcinoma (RCC). Although tumour stage and grade can provide important information, they fail to consider patient‐ and tumour‐specific bio
Externí odkaz:
https://doaj.org/article/0bcb2d99e3854524804cd562ce4b15eb
Publikováno v:
Biomedicines, Vol 9, Iss 8, p 1033 (2021)
Cisplatin is one of the most commonly used drugs for the treatment of various solid cancers. However, its efficacy is restricted by severe side effects, especially dose-limiting nephrotoxicity. New platinum-based compounds are designed to overcome th
Externí odkaz:
https://doaj.org/article/12409681554c46018ef0c98d0c12027d
Publikováno v:
Human Brain Mapping. 44:3506-3518
Autor:
Roger de Alwis, Sarah Schoch, Mazharul Islam, Christina Möller, Börje Ljungberg, Håkan Axelson
Publikováno v:
The Journal of Pathology: Clinical Research.
Prognostic tools are an essential component of the clinical management of patients with renal cell carcinoma (RCC). Although tumour stage and grade can provide important information, they fail to consider patient- and tumour-specific biology. In this
Publikováno v:
Molecular and Clinical Oncology
Autor:
Roger, De Alwis, Jennifer, Hansson, David, Lindgren, Sarah, Schoch, Alexander, Tejera, Bianca, Scholtz, Peter, Elfving, Christina, Möller, Helén, Nilsson, Martin, Johansson, Håkan, Axelson
Publikováno v:
Molecular and clinical oncology. 16(5)
Renal cell carcinoma (RCC) is a tumour type with an indolent growth pattern and rather vague symptoms. The present study developed a platform for liquid biopsy of RCC based upon the isolation of circulating tumour cells (CTCs). Founded on the observa
Autor:
Sarah Schoch, Beate Köberle
Publikováno v:
Cancers, 13 (9), Art.-Nr.: 2073
Cancers, Vol 13, Iss 2073, p 2073 (2021)
Cancers
Cancers, Vol 13, Iss 2073, p 2073 (2021)
Cancers
Simple Summary Cisplatin is successfully used for the treatment of various solid cancers. Unfortunately, it shows no activity in colorectal cancer. The resistance phenotype of colorectal cancer cells is mainly caused by alterations in p53-controlled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e011c875a0133da4db8d1509b652737
https://publikationen.bibliothek.kit.edu/1000132341/112618152
https://publikationen.bibliothek.kit.edu/1000132341/112618152
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 6928, p 6928 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 18
International journal of molecular sciences, 21 (18), Art. Nr.: 6928
International Journal of Molecular Sciences
Volume 21
Issue 18
International journal of molecular sciences, 21 (18), Art. Nr.: 6928
Platinum drugs are among the most effective anticancer agents, but their mode of action is still not fully understood. We therefore carried out a systematic investigation on the cellular activities of cisplatin, carboplatin and oxaliplatin in A498 ki
Publikováno v:
Chemical research in toxicology. 33(5)
To assess the toxicity of nanomaterials, most in vitro studies have been performed under submerged conditions, which do not reflect physiological conditions upon inhalation. An air-liquid interface (ALI) exposure may provide more reliable data on dos
Autor:
Beate Köberle, Bettina Maria Strauch, Valery G. Golubev, Andrea Hartwig, Sabine Gajewski, Vasily D. Sen, Sarah Schoch
Publikováno v:
Biochemical Pharmacology. 156:109-119
The efficacy of the anticancer drug cisplatin is restricted by tumor cell resistance and occurrence of severe side effects. One strategy to overcome these limitations is the development of new, improved platinum drugs. Previous investigations showed